You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 2.5% |
| Div Cover | n/a | 79.2 |
| Op Mrgn | 0.0% | 91.1% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -21.0 | 0.5 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.4 |
| Price / Book value | 4.7 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 73.8% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 5.03 | 1.63 | 1.92p | 5.6 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.10 | -4.10 | -3.45p | -3.8 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -4.79 | -3.53p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -17.73 | -9.46p | -16.2 | 0.0 | n/a | n/a | 0.0% |
| Synairgen secures patients for phase III study of Covid treatment, shares jump Sharecast News | 11 Nov |
|---|---|
| Synairgen drug proves effective against Covid variants in lab tests Sharecast News | 24 May |
| Synairgen confirms start of dosing in Covid-19 trial Sharecast News | 15 Feb |
| Holding(s) in Company | 19-Jan-22 14:05 |
|---|---|
| Holding(s) in Company | 12-Jan-22 11:54 |
| Holding(s) in Company | 07-Jan-22 17:25 |
| Synairgen announces partnership with Ashfield | 06-Jan-22 12:00 |
| Holding(s) in Company | 23-Dec-21 16:14 |